STING Agonists

Cat.No. Product Name Information Product Use Citations Product Validations
S8796 diABZI STING agonist-1 (tautomerism) diABZI STING agonist (diABZI STING agonist-1, Compound 3, Tautomerism) is a potent non-nucleotide STING agonist and has tremendous potential to improve treatment of cancer in humans.Solutions are unstable and should be fresh-prepared.
Cell Discov, 2025, 11(1):23
Nat Biomed Eng, 2025, 10.1038/s41551-025-01400-0
J Exp Med, 2025, 222(5)e20241184
S7904 2',3'-cGAMP Sodium Salt 2',3'-cGAMP Sodium Salt (2'-3'-cyclic GMP-AMP Sodium) is produced in response to DNA in the cytoplasm in mammalian cells and binds STING with high affinity and is an effective inducer of interferon-β (IFNβ). 2',3'-cGAMP Sodium Salt binds to STING with Kd of 3.79 nM.
J Nanobiotechnology, 2025, 23(1):724
Cancer Sci, 2025, 10.1111/cas.70162
J Biol Chem, 2025, 301(10):110653
S0853 SR-717 lithium SR-717 lithium is a non-nucleotide STING agonist that demonstrates broad interspecies and interallelic specificity with EC50 of 2.1 μM and 2.2 μM in ISG-THP1 (WT) and ISG-THP1 (cGAS KO) cell lines, respectively. SR-717 lithium also induces the expression of clinically relevant targets, including programmed cell death 1 ligand 1 (PD-L1), in a STING-dependent manner. SR-717 lithium exhibits antitumor activity.
Nat Commun, 2025, 16(1):3440
Pharmaceutics, 2024, 16(9)1216
Mol Neurobiol, 2022, 59(11):7006-7024
S9681 MSA-2 MSA-2 is an orally available non-nucleotide human STING agonist with antitumour activity.
J Colloid Interface Sci, 2025, 686:1019-1032
Cell Discov, 2022, 8(1):133
S8954 G10 (STING agonist-1) G10 (STING agonist-1) is a novel human-specific STING agonist that triggers IFN regulatory factor 3 (IRF3)/ type I interferon (IFN)-associated transcription in human fibroblasts. This compound potently reduces growth of Chikungunya virus (CHIKV) with IC90 of 8.01 μM and blocks replication of Alphavirus species Venezuelan Equine Encephalitis Virus (VEEV) with IC90 of 24.57 μM.
Int J Biol Sci, 2023, 19(11):3428-3440
E5921New ZSA-51 ZSA-51 is a potent oral agonist of STING. It exhibits potent antitumor efficacy in colon and pancreatic cancer, with superior oral PK, low toxicity, and immune microenvironment remodelling in tumours and lymph nodes.
S9618 E7766 diammonium salt E7766 diammonium salt, a macrocycle-bridged STING agonist with a Kd of 40 nM, shows potent pan-genotypic and antitumor activities.
E1881 NVS-STG2 NVS-STG2(HY-157214) is a potent, allosteric small molecule agonist of STING. It binds at the transmembrane domain (TMD) interface of STING, thereby acting as a molecular glue to promote STING oligomerization and contribute to its activation. It may be used in research of STING-related autoimmune diseases.
E1835 diABZI STING agonist-1 trihydrochloride diABZI STING agonist-1 trihydrochloride is a selective stimulator of the interferon genes STING receptor, acting as an agonist with EC50 of 130 nM for human STING and 186 nM for mouse STING.
E2664 Cridanimod Cridanimod, a low-Mw interferon-inducer (IFN-inducer), recognises the intracellular signalling protein stimulator of interferon genes (STING), resulting in the STING-TBK1-IRF3 pathway activation and synthesis of type I IFNs (subtypes IFN-α and IFN-β).
S1537 Vadimezan (DMXAA) Vadimezan (DMXAA) is a vascular disrupting agents (VDA) and competitive inhibitor of DT-diaphorase with Ki of 20 μM and IC50 of 62.5 μM in cell-free assays, respectively. It is also a STING agonist with potential antineoplastic activity, potently inducing IFN-β but relatively low TNF-α expression in vitro. This compound has antiviral activity. Phase 3.
Cell Chem Biol, 2025, 32(2):280-290.e14
Commun Biol, 2025, 8(1):1470
Front Pharmacol, 2025, 16:1528459
Verified customer review of Vadimezan (DMXAA)
S3804 Alpha-Mangostin Alpha-Mangostin is the main xanthone purified from mangosteen and has health promoting benefits including anti-bacterial, anti-inflammatory, anti-oxidant, anti-cancer and cardioprotective activities. Alpha-Mangostin (α-Mangostin) is a dietary xanthone with broad biological activities, such as antioxidant, anti-allergic, antiviral, antibacterial, anti-inflammatory and anticancer effects. It is an inhibitor of mutant IDH1 (IDH1-R132H) with a Ki of 2.85 μM. Alpha-mangostin is also an agonist of human STING.
Int J Mol Sci, 2024, 25(13)7378
Front Pharmacol, 2021, 12:692806